Table 1.
Characteristics | Sunitinib | Sorafenib | P Value |
---|---|---|---|
Total no. Patient | 58 | 50 | |
No. Patients With Sufficient Data to Analyze | 45 | 28 | .3 |
Mean (SD) Age, y | 59 ± 9.7 | 60 ± 8.1 | .73 |
Men, no. (%) | 40 (69) | 41 (82) | .12 |
Prior Sunitinib Therapy, The Number of Patients | — | 5 | |
Prior Sorafenib Therapy, The Number of Patients | 6 | — | |
No. (%) Patients With a History of Hypothyroidism at Baseline | 11 (19) | 6 (12) | .77 |